Literature DB >> 6685224

DNA-binding peptides from rat liver and Novikoff hepatoma cells: quantitative level and possible biochemical differences.

G L Gianfranceschi, D Barra, S Coderoni, M Paparelli, F Venanzi, D Amici.   

Abstract

DNA isolated from rat liver by intensive deproteinization with chloroform/isoamyl alcohol and phenol contains low molecular weight peptides in a quantity of about 20 micrograms/mg DNA. These peptides show high specific activity in inhibiting transcription in a reconstituted cell-free system with prokaryotic and eukaryotic RNA polymerase. Their level is markedly decreased in DNA prepared from Novikoff hepatoma cells. Moreover the amino acid analysis and the pattern of analytical separation by high performance liquid chromatography (HPLC) show some biochemical differences between DNA-binding peptides extracted from rat liver and Novikoff hepatoma cells. The possibility that carcinogenesis may involve mechanisms which lead to selective removal of some components of the DNA-binding peptides, is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685224     DOI: 10.1007/bf00775363

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  14 in total

1.  Tumour promotor induces plasminogen activator.

Authors:  M Wigler; I B Weinstein
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

2.  Evidence for the presence in calf thymus of a peptidic factor controlling DNA transcription in vitro.

Authors:  G L Gianfranceschi; D Amici; L Guglielmi
Journal:  Biochim Biophys Acta       Date:  1975-11-18

3.  Specific thymic peptides-DNA interaction. Correlation with the possible stereochemical kinking scheme of DNA.

Authors:  L Guglielmi; G L Gianfranceschi; F Venanzi; A Polzonetti; D Amici
Journal:  Mol Biol Rep       Date:  1979-02-15       Impact factor: 2.316

4.  Control of RNA and protein synthesis in phytohemagglutinin-stimulated human lymphocytes by chromatin peptides from calf thymus.

Authors:  D Amici; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1980-12-31       Impact factor: 2.316

5.  Inhibition of protein synthesis by low molecular weight factor(s) extracted from bovine seminal plasma.

Authors:  G Lugaro; M G Leonardi
Journal:  Cell Biol Int Rep       Date:  1982-05

6.  Low molecular weight peptides controlling transcription are present in the calf thymus chromatin structure.

Authors:  G L Gianfranceschi; L Guglielmi; D Amici; F Bossa; D Barra; R Petruzzelli
Journal:  Mol Biol Rep       Date:  1977-12       Impact factor: 2.316

7.  Effects of a chromatin low molecular weight peptidic fraction on differentiation markers and virus production in Friend leukemia cells.

Authors:  G B Rossi; L Cioe; S Pulciani; P Meo; F Titti; D Amici; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1979-12-31       Impact factor: 2.316

8.  Control of transcription and translation by low molecular weight peptides (deprimerones) from chromatin and poly(A)-messenger RNA. Implication in the mechanism of carcinogenesis.

Authors:  M Hillar; J Przyjemski
Journal:  Biochim Biophys Acta       Date:  1979-09-27

9.  A protease inhibitor blocks SOS functions in Escherichia coli: antipain prevents lambda repressor inactivation, ultraviolet mutagenesis, and filamentous growth.

Authors:  M S Meyn; T Rossman; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  Low molecular weight peptidic fraction in the chromatin from normal and cancer cells: control of transcription.

Authors:  G L Gianfranceschi; M Hillar; J T Chan; D Amici
Journal:  Mol Biol Rep       Date:  1980-07-31       Impact factor: 2.316

View more
  1 in total

1.  A class of DNA-binding peptides from wheat bud causes growth inhibition, G2 cell cycle arrest and apoptosis induction in HeLa cells.

Authors:  Loretta Mancinelli; Paula M De Angelis; Lucia Annulli; Valentina Padovini; Kjell Elgjo; Gian Luigi Gianfranceschi
Journal:  Mol Cancer       Date:  2009-07-31       Impact factor: 27.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.